GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity, high blood ...

Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...

My year of unraveling is how a despairing Christy Morrill described nightmarish months when his immune system hijacked his ...

Of all the ways our immune system can run amok and damage the body instead of protecting it, autoimmune encephalitis is one ...

Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

Caplan says as America ages, dementia cases may double in the coming decades, making prevention more urgent than ever. If you ...

An international survey has revealed that electroconvulsive therapy (ECT) causes a much broader and more damaging range of ...

Scientists studying young adults with obesity discovered early indicators of brain stress that resemble patterns seen in cognitive impairment. The group showed higher inflammation, signs of liver ...

Novo Nordisk A/S remains a Strong Buy despite semaglutide's Alzheimer's trial miss. Click for NVO growth drivers, solid ...